Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06507722Not ApplicableRecruiting

Night Owl Metabolism

Role: collaborator

NCT04984798Phase 2Withdrawn

Vitamin E Efficacy in HI/HA

Role: collaborator

NCT03797222Not ApplicableCompleted

Vitamin E Supplementation in Hyperinsulinism/Hyperammonemia Syndrome

Role: collaborator

NCT00577174Unknown

Mitochondrial Function in Pediatric Obesity

Role: collaborator

All 4 trials loaded